Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT02111096

Public ClinicalTrials.gov record NCT02111096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 11:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The intent of this study is to assess the safety of LY2409021 in participants with Type 2 diabetes mellitus taking metformin and sulfonylurea as prescribed by their personal physician. The study treatment is expected to last 12 months (52 weeks).

Study identification

NCT ID
NCT02111096
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
174 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 79 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2014 (Type not available)
Primary completion
Sep 2015 (Actual)
Completion
Sep 2015 (Actual)
Last update posted
Oct 9, 2019

2014 – 2015

United States locations

U.S. sites
26
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
John Muir Health Network - The Osteoporosis Center Concord California 94520 —
Valley Endocrine, Fresno Fresno California 93720 —
National Research Institute Los Angeles California 90057 —
Suncoast Research Group, LLC Miami Florida 33135 —
New Horizon Research Center Miami Florida 33175 —
Clinical Research of West Florida, Inc. Tampa Florida 33603 —
University of Hawaii Honolulu Hawaii 96813 —
East West Medical Institute Honolulu Hawaii 96814 —
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404 —
Cedar-Crosse Research Center Chicago Illinois 60607 —
Midwest CRC Crystal Lake Illinois 60012 —
Iderc, P.L.C. Des Moines Iowa 50314 —
Cotton O'Neil Clinic Topeka Kansas 66606 —
Centex Studies, Inc Lake Charles Louisiana 70601 —
Cosmopolitan International Diabetes Center Columbia Missouri 65212 —
Mercy Medical Research Institute Springfield Missouri 65807 —
Palm Research Center Las Vegas Nevada 89148 —
SHS Clinical Research Group Toms River New Jersey 08753 —
Office:Alwine,Lk Downingtown Pennsylvania 19335 —
University Diabetes and Endocrine Consultants Chattanooga Tennessee 37411 —
Dallas Diabetes Endocrine Center Dallas Texas 75230 —
Galenos Research Dallas Texas 75251 —
San Gabriel Clinical Research Georgetown Texas 78626 —
Oakwell Clinical Research San Antonio Texas 78218 —
Victorium Clinical Research San Antonio Texas 78240 —
Polyclinic Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02111096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2019 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02111096 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →